Ligand ID: DB8 Drugbank ID: DB06616 (Bosutinib) Indication: Treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy in adult patients.